Wafik El-Deiry
Chair, WIN Consortium; Director, Legorreta Cancer Center at Brown University (USA)
Executive committee
Razelle Kurzrock
Chief Medical Officer, WIN Consortium; Prof. of Medicine, Associate Director Clinical Research, MCW Cancer Center and Linda T. & John A. Mellowes Chair of Precision Oncology (USA)
Sewanti Limaye
Vice Chair, WIN Consortium; Director of Medical & Precision Oncology, Clinical & Translational Oncology Research, Sir H.N. Reliance Foundation Hospital & Research Centre (India)
Apostolia-Maria Tsimberidou
Vice Chair, WIN Consortium; Professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center (USA)
Richard L. Schilsky
Chair Emeritus, WIN Consortium; Professor Emeritus, University of Chicago; past President and former Executive Vice President & Chief Medical Officer (ASCO) (USA)
Marina Sekacheva
Head of the Membership Committee, WIN Consortium; Director of Institute for Personalized Oncology, I.M. Sechenov First Moscow State Medical University, Sechenov University (Russia)
Jacques Raynaud
Senior adviser in WIN Strategy, Science and Fundraising, WIN Consortium
Catherine Bresson
Director, Operational Team, WIN Consortium
Operational team
Catherine Bresson
Director, Operational Team, WIN Consortium
Layla El-Gharras
Assistant, Operational Team, WIN Consortium
Shai Magidi
IT Data Management, WIN Consortium
Eitan Rubin
Head of Bioinformatics, WIN Consortium; Associate Professor, Ben-Gurion University of the Negev (Israel)
Fanny Wunder
Project Manager, WIN Consortium
Scientific Advisory Board
Yves A. Lussier
Chairman, Scientific Advisory Board, WIN Consortium; Professor and Chair, Department of Biomedical Informatics, The University of Utah School of Medicine (USA)
Liang Cheng
Vice-Chair, SAB, WIN Consortium; Professor of Pathology and Surgery/Urology, Vice Chair for Translational Research, Brown University Warren Alpert Medical School (USA)
Roy S. Herbst
Vice-Chair, SAB, WIN Consortium; Ensign Professor of Medicine; Chief of Medical Oncology; Deputy Director of Yale Cancer Center and Smilow Cancer Hospital (USA)
Sewanti Limaye
Vice Chair, WIN Consortium; Director of Medical & Precision Oncology, Clinical & Translational Oncology Research, Sir H.N. Reliance Foundation Hospital & Research Centre (India)
Apostolia-Maria Tsimberidou
Vice Chair, WIN Consortium; Professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center (USA)
Stephen G. Chun
Radiation Oncologist, Co-Host, NRG Oncology Podcast. Director, Radiation Oncology Clinical Research, The University of Texas, MD Anderson Cancer Center (USA)
William L. Dahut
Chief Scientific Officer, American Cancer Society (USA)
Don S. Dizon
Service Line Chief of Hematology-Oncology at Tufts Medicine, Jane F. Desforges Endowed Chair in Hematology and Oncology, Professor of Medicine, Tufts University (USA)
Keith T. Flaherty
Director, Clinical Research, Massachusetts General Hospital Cancer Center; Professor of Medicine at Harvard Medical School & AACR President Elect 2025-2026 (USA)
Naftali Z. Frankel
Director of Precision Medicine Innovation, Chaim Medical Resource, Org, (USA)
Ruben A. Mesa
President, Atrium Health Levine Cancer Executive Director, Atrium Health Wake Forest Baptist Comprehensive Cancer Center (USA)
Gregory Riedlinger
Chief of Molecular Pathology, Professor of Pathology, Director, Biorepository Services, Rutgers Cancer Institute, (USA)
Jens Rueter
Chief Medical Officer, Jackson Laboratory & Medical Director – Maine Cancer Genomics Initiative, The Jackson Laboratory (USA)
Vivek Subbiah
Chief of Early-Phase Drug Development, Sarah Cannon Research Institute, (USA)
Joann Sweasy
Director of the Fred and Pamela Buffett Cancer Center, Director of the Eppley Institute for Cancer Research at the University of Nebraska (USA)
Directorate
Wafik El-Deiry
Chair, WIN Consortium; Director, Legorreta Cancer Center at Brown University (USA)
Razelle Kurzrock
Chief Medical Officer, WIN Consortium; Prof. of Medicine, Associate Director Clinical Research, MCW Cancer Center and Linda T. & John A. Mellowes Chair of Precision Oncology (USA)
Sewanti Limaye
Vice Chair, WIN Consortium; Director of Medical & Precision Oncology, Clinical & Translational Oncology Research, Sir H.N. Reliance Foundation Hospital & Research Centre (India)
Apostolia-Maria Tsimberidou
Vice Chair, WIN Consortium; Professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center (USA)
Marina Sekacheva
Head of the Membership Committee, WIN Consortium; Director of Institute for Personalized Oncology, I.M. Sechenov First Moscow State Medical University, Sechenov University (Russia)
Gerald Batist
Director, Segal Cancer Centre, Sir Mortimer B. Davis-Jewish General Hospital, McGill Centre for Translational Research in Cancer, McGill University (Canada)
Cristiano de Pádua Souza
Medical Oncologist, Department of Oncology, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)
Carol Farhangfar
Assistant Vice President, Translational Research, Wake Forest Baptist Comprehensive Cancer Center/Atrium Health (USA)
Naftali Z. Frankel
Director of Precision Medicine Innovation, Chaim Medical Resource, Org, (USA)
Sadakatsu Ikeda
Professor, Department Chief, Department of Precision Cancer Medicine, Institute of Science Tokyo Hospital (Japan)
Jia Liu
Staff Specialist Medical Oncology and Translational Lead of Phase 1 Unit, The Kinghorn Cancer Center, St Vincent's Hospital (Australia)
Tobias Meissner
Cancer Genomics Manager, Avera Cancer Institute (USA)
Khaled Musallam
Group Chief Research Officer, Burjeel Holdings, Founding Director, Center for Research on Rare Blood Disorders (CR-RBD); Burjeel Medical City (United Arab Emirates)
Amir Onn
Head of Standard Operating Procedures and Repository Committee, WIN Consortium; Chair, Institute of Pulmonary Oncology, Sheba Medical Center (Israel)
Alejandro Piris
Chief Scientific Officer, Vall d'Hebron Institute of Oncology, VHIO (Spain)
Angel Porgador
Professor and Dean, Faculty of Health Sciences, Ben-Gurion University of the Negev (Israel)
C.S. Pramesh
Director, Tata Memorial Hospital; Professor, Thoracic Surgery, Division of Surgical Oncology, Tata Memorial Centre (India)
Eitan Rubin
Head of Bioinformatics, WIN Consortium; Associate Professor, Ben-Gurion University of the Negev (Israel)
Jens Rueter
Chief Medical Officer, Jackson Laboratory & Medical Director – Maine Cancer Genomics Initiative, The Jackson Laboratory (USA)
Pierre Saintigny
Medical Oncologist, Professor of Medicine at University Claude Bernard Lyon, Coordinator of the Translational Medicine Unit at Centre Léon Bérard (France)
Ramón Salazar
General Director, Catalan Institute of Oncology (ICO)(Spain)
Benjamin M. Solomon
Medical Oncologist, Avera Cancer Institute (USA)
General Assembly
Wafik El-Deiry
Chair, WIN Consortium; Director, Legorreta Cancer Center at Brown University (USA)
Sewanti Limaye
Vice Chair, WIN Consortium; Director of Medical & Precision Oncology, Clinical & Translational Oncology Research, Sir H.N. Reliance Foundation Hospital & Research Centre (India)
Marina Sekacheva
Head of the Membership Committee, WIN Consortium; Director of Institute for Personalized Oncology, I.M. Sechenov First Moscow State Medical University, Sechenov University (Russia)
Hikmat Abdel-Razeq
Professor and Chairman, Department of Medicine, Chief Medical Officer and Deputy Director General King Hussein Cancer Center (Jordan)
Amal Al Omari
Chief Scientific Officer, King Hussein Cancer Center (Jordan)
Humaid Al-Shamsi
Chief Executive Officer of Burjeel Cancer Institute (UAE & GCC), (United Arab Emirates)
Satoru Aoyama
Assistant Professor, Institute of Science Tokyo Hospital (Japan)
Jair Bar
Head, Thoracic Oncology, Institute of Oncology, Sheba Medical Center (Israel)
Gerald Batist
Director, Segal Cancer Centre, Sir Mortimer B. Davis-Jewish General Hospital, McGill Centre for Translational Research in Cancer, McGill University (Canada)
Guy Berchem
Medical Director, Centre Hospitalier de Luxembourg; Associate Medical Director, Luxembourg Institute of Health (Luxembourg)
Raanan Berger
Director, Institute of Oncology, Sheba Medical Center (Israel)
Jean-Yves Blay
General Director, Centre Léon Bérard (France)
Anca Dana Buzoianu
Rector, Head of Chair: Pharmacology, toxicology and clinical pharmacology, The University of Medicine and Pharmacy Iuliu Haţieganu (Romania)
Benedito A. Carneiro
Co-Leader Cancer Therapeutics Program, Legorreta Cancer Center at Brown University (USA)
Andrés Cervantes
Head of Department, INCLIVA (Spain)
William L. Dahut
Chief Scientific Officer, American Cancer Society (USA)
Cristiano de Pádua Souza
Medical Oncologist, Department of Oncology, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)
Said Dermime
Senior Scientist/ Director of Translational Cancer Research Facility, National Center for Cancer Care & Research Hamad Medical Corporation (Qatar)
Carol Farhangfar
Assistant Vice President, Translational Research, Wake Forest Baptist Comprehensive Cancer Center/Atrium Health (USA)
Amanda Ferraro
Patient Advocate, Author, Freelance Writer, Cancer is an A* LLC (USA)
Naftali Z. Frankel
Director of Precision Medicine Innovation, Chaim Medical Resource, Org, (USA)
Himabindu Gaddipati
Founder and Managing Director, Vyas Cancer Research Pvt (VCR Park) (India)
Manon Gantenbein
Head of Clinical and Epidemiological Investigation Center (CIEC) & Clinical Project Management Office (CPMO), Luxembourg Institute of Health (Luxembourg)
Eugenia Girda
Assistant Professor of Obstetrics, Gynecology and Reproductive Sciences and Division of Gynecologic Oncology, Rutgers Cancer Institute (USA)
Kerri Gober
Associate Chief of Staff, Discovery, American Cancer Society (USA)
Leah Graham
Program Director, Maine Cancer Genomics Initiative, The Jackson Laboratory (USA)
Sadakatsu Ikeda
Professor, Department Chief, Department of Precision Cancer Medicine, Institute of Science Tokyo Hospital (Japan)
Simon Istolainen
Chief Strategy and Scientific Network, Cure51 (France)
Anthony Joshua
Head of Department, Department of Medical Oncology, The Kinghorn Cancer Centre, St Vincent's Hospital (Australia)
Mandar Kulkarni
CEO and Director, Vyas Cancer Research Pvt (VCR Park) (India)
Jia Liu
Staff Specialist Medical Oncology and Translational Lead of Phase 1 Unit, The Kinghorn Cancer Center, St Vincent's Hospital (Australia)
Chetan Madre
Oncology Research- Manager, Sir H.N. Reliance Foundation Hospital & Research Centre (India)
Juan Martín-Liberal
Consultant Medical Oncologist Melanoma, Sarcoma and GU Tumors Unit Early Drug Development Unit, Catalan Institute of Oncology (ICO)(Spain)
Ruben A. Mesa
President, Atrium Health Levine Cancer Executive Director, Atrium Health Wake Forest Baptist Comprehensive Cancer Center (USA)
Tobias Meissner
Cancer Genomics Manager, Avera Cancer Institute (USA)
Khaled Musallam
Group Chief Research Officer, Burjeel Holdings, Founding Director, Center for Research on Rare Blood Disorders (CR-RBD); Burjeel Medical City (United Arab Emirates)
Amir Onn
Head of Standard Operating Procedures and Repository Committee, WIN Consortium; Chair, Institute of Pulmonary Oncology, Sheba Medical Center (Israel)
Jim Palma
Chief Executive Officer of TargetCancer Foundation (USA)
Alejandro Piris
Chief Scientific Officer, Vall d'Hebron Institute of Oncology, VHIO (Spain)
Angel Porgador
Professor and Dean, Faculty of Health Sciences, Ben-Gurion University of the Negev (Israel)
C.S. Pramesh
Director, Tata Memorial Hospital; Professor, Thoracic Surgery, Division of Surgical Oncology, Tata Memorial Centre (India)
Rui Manuel Reis
Scientific Director, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)
Gregory Riedlinger
Chief of Molecular Pathology, Professor of Pathology, Director, Biorepository Services, Rutgers Cancer Institute, (USA)
Abdul Rouf
Senior Research Scientist – Director of Clinical Trial Unit, National Center for Cancer Care & Research Hamad Medical Corporation (Qatar)
Eitan Rubin
Head of Bioinformatics, WIN Consortium; Associate Professor, Ben-Gurion University of the Negev (Israel)
Jens Rueter
Chief Medical Officer, Jackson Laboratory & Medical Director – Maine Cancer Genomics Initiative, The Jackson Laboratory (USA)
Pierre Saintigny
Medical Oncologist, Professor of Medicine at University Claude Bernard Lyon, Coordinator of the Translational Medicine Unit at Centre Léon Bérard (France)
Ramón Salazar
General Director, Catalan Institute of Oncology (ICO)(Spain)
Mohamed E. Salem
Clinical Associate Professor, Hematology and Oncology, Wake Forest Baptist Comprehensive Cancer Center/Atrium Health (USA)
Pessie Schlafrig
Co-founder and Director, Chaim Medical Resource, Org (USA)
Manju Sengar
Professor, Medical Oncology - Tata Memorial Center (India)
Shambhavi Singh
Precision Oncology Research Fellow, Division of Precision Oncology and Medical Oncology, Sir H N Reliance Foundation Hospital and Research Centre (India)
Benjamin M. Solomon
Medical Oncologist, Avera Cancer Institute (USA)
Andrey A. Svistunov
First Vice Rector, I.M Sechenov First Moscow State Medical University (Russia)
Josep Tabernero
Head, Medical Oncology Department, Vall d'Hebron University Hospital (HUVH); Director, Vall d'Hebron Institute of Oncology, VHIO (Spain)
Mohammed Ussama Al Homsi
Senior Consultant Oncology, National Center for Cancer Care & Research Hamad Medical Corporation (Qatar)
Nicolas Wolikow
Chief Executive Officer, Cure51 (France)